NCT00006202View on ClinicalTrials.gov

Lutein for Age-Related Macular Degeneration

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 30, 2000

Study Completion Date

August 31, 2003

Conditions
Macular Degeneration
Interventions
DRUG

Lutein

Trial Locations (1)

20892

National Eye Institute (NEI), Bethesda

All Listed Sponsors
lead

National Eye Institute (NEI)

NIH

NCT00006202 - Lutein for Age-Related Macular Degeneration | Biotech Hunter | Biotech Hunter